Canton Strategic Holdings (CNTN) Shares Issued (2022 - 2026)
Canton Strategic Holdings posted quarterly Shares Issued of $94711.0 for Q1 2026, up 194.36% on a QoQ basis from -$100375.0 in Q4 2025.
Canton Strategic Holdings (CNTN) has 5 years of Shares Issued data on file, last reported at $94711.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $94711.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $166250.0, down 95.95% from the prior year.
- Shares Issued for Q1 2026 stood at $94711.0, up from -$100375.0 in the prior quarter.
- Across five years, Shares Issued topped out at $13.6 million in Q1 2022 and bottomed at -$13.6 million in Q2 2022.
- The 5-year median for Shares Issued is -$2832.0 (2025), against an average of -$6512.5.
- The widest annual swing landed in 2024, when Shares Issued jumped 189.59%; it then slumped 104.97% in 2025.
- A 5-year view of Shares Issued shows it stood at -$13.6 million in 2022, then jumped by 83.45% to -$2.3 million in 2023, then jumped by 189.59% to $2.0 million in 2024, then tumbled by 104.97% to -$100375.0 in 2025, then surged by 194.36% to $94711.0 in 2026.
- The last three Shares Issued figures came in at $94711.0 (Q1 2026), -$100375.0 (Q4 2025), and $2.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 94,711.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94,711.00 |
| Mar 31, 2026 | 94,711.00 |
| Dec 31, 2025 | -100,375.00 |
| Dec 31, 2025 | -100,375.00 |
| Dec 31, 2024 | 2.02 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | -2.25 Mn |
| Dec 31, 2023 | -2.25 Mn |
| Sep 30, 2023 | -386,174.00 |
| Sep 30, 2023 | -386,174.00 |
| Jun 30, 2023 | 550,000.00 |
| Jun 30, 2023 | 550,000.00 |
| Jun 30, 2022 | -13.62 Mn |
| Jun 30, 2022 | -13.62 Mn |
| Mar 31, 2022 | 13.65 Mn |
| Mar 31, 2022 | 13.65 Mn |